Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

UPDATE 1-NZ's Fisher & Paykel sues Resmed in Australia over patent dispute

Published 12/12/2017, 01:11 pm
Updated 12/12/2017, 01:20 pm
© Reuters.  UPDATE 1-NZ's Fisher & Paykel sues Resmed in Australia over patent dispute

(Adds background, shares movement)

Dec 12 (Reuters) - New Zealand's Fisher & Paykel Healthcare FPH.NZ filed a lawsuit in Australia on Tuesday against Resmed Inc RMD.N alleging the medical device manufacturer's respiratory treatment products violate four Fisher & Paykel patents.

Fisher & Paykel said it was seeking a range of legal remedies from the lawsuit, including banning the manufacture and sale of such Resmed products in Australia.

The company added its earnings forecast for fiscal 2018 remained unchanged.

Fisher & Paykel and California-based Resmed are engaged in patent disputes in several countries over medical devices used to treat respiratory conditions.

Fisher & Paykel had filed a case against Resmed in Britain in 2016 and said last month it could continue to sell its sleep apnea masks in the country after a UK court ruled Resmed's patent was invalid. was not immediately available for a comment.

Fisher & Paykel shares were about 1 percent lower after the announcement, in a lower overall market in New Zealand. Resmed's Australia shares RMD.AX were down about 1 percent while the larger Australian market traded flat.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.